Similar Articles

• PS2-13: Genetic and Environmental Risk Factors for Prescription Opioid Dependence in the Healthcare Setting

  Joseph A Boscarino, Stuart N Hoffman, Glenn Gerhard, John Han, Margaret Rukstalis, Porat M Erlich and Walter F Stewart

  • Clinical Medicine & Research March 2010, 8 (1) 51;
  • DOI: https://doi.org/10.3121/cmr.8.1.51
• Evaluation of Genetic Factors for Warfarin Dose Prediction

  Michael D. Caldwell, Richard L. Berg, Kai Qi Zhang, Ingrid Glurich, John R. Schmelzer, Steven H. Yale, Humberto J. Vidaillet and James K. Burmester

  • Clinical Medicine & Research March 2007, 5 (1) 8-16;
  • DOI: https://doi.org/10.3121/cmr.2007.724
• PS3-8: Identification of Severe Cutaneous Reactions and Genomic Risk Factors in Users of Antiepileptic Drugs

  Mia Gallagher, Maryam Asgari, Joseph Boscarino, James Burmester, Lee Cromwell, Melody Eide, Heather Feigelson, Jennifer Kuntz, Lois La Grenade, Eric Macy and David Margolis

  • Clinical Medicine & Research September 2013, 11 (3) 170;
  • DOI: https://doi.org/10.3121/cmr.2013.1176.ps3-8
• PS3-28: Telemedicine Specialty Consultation in a Medically Underserved Community

  Ted Palen and Mike Bodily

  • Clinical Medicine & Research December 2010, 8 (3-4) 200-201;
  • DOI: https://doi.org/10.3121/cmr.2010.943.ps3-28
• C-B4-02: Determining Genetic Risk Factors for Post- Hospitalization development of Deep-Vein Thrombosis

  Deanna Cross, Mark Craven and Steven Yale

  • Clinical Medicine & Research December 2010, 8 (3-4) 202;
  • DOI: https://doi.org/10.3121/cmr.2010.943.c-b4-02
• Use of Chromogenic Assay of Factor X to Accept or Reject INR Results in Warfarin Treated Patients

  Michael J. Sanfelippo, Wendy Zinsmaster, Doris L. Scherr and Gene R. Shaw

  • Clinical Medicine & Research July 2009, cmr.2009.836;
  • DOI: https://doi.org/10.3121/cmr.2009.836
• Use of Chromogenic Assay of Factor X to Accept or Reject INR Results in Warfarin Treated Patients

  Michael J. Sanfelippo, Wendy Zinsmaster, Doris L. Scherr and Gene R. Shaw

  • Clinical Medicine & Research September 2009, 7 (3) 103-105;
  • DOI: https://doi.org/10.3121/cmr.2009.836
• PS3-12: Obesity and Risk of Proliferative Hyperplastic Lesions

  Melissa Stahl, James Evans and Azadeh Stark

  • Clinical Medicine & Research December 2010, 8 (3-4) 195;
  • DOI: https://doi.org/10.3121/cmr.2010.943.ps3-12
• PS1-36: Developing Rapid Molecular E.coli Clonal Diagnostics for Community Laboratory Settings

  Delia Scholes, Kim Riddell, Jackie Saint-Johnson, Peggy Rogers, Veronika Tchesnokova and Evgeni Sokurenko

  • Clinical Medicine & Research September 2014, 12 (1-2) 109;
  • DOI: https://doi.org/10.3121/cmr.2014.1250.ps1-36
• Frequency of Cardiovascular Risk Factors and Metabolic Syndrome in Patients with Chronic Kidney Disease

  Gul Sagun, Gulcin Kantarci, Banu Mesci, Sinem Gungor, Funda Turkoglu, Elif Yorulmaz and Aytekin Oguz

  • Clinical Medicine & Research December 2010, 8 (3-4) 135-141;
  • DOI: https://doi.org/10.3121/cmr.2010.892

Previous

Next

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• …
• 195